Investors & Media

홈Investors & MediaNews release

News release

게시물 상세
News Dr. Sang Won Kang attended a business exchange meeting at the Korea Biotech Industry Organization
VasThera( : 2022-10-27View : 166

▲ The representatives of the participating companies


Dr. Sang Won Kang, CEO of VasThera, attended a member company's CEO exchange meeting at the Korea Biotechnology Industry Organization on October 14.

Prev VasThera and KDDF sign agreement to advance drug discovery in South Korea
Next VasThera signs MoU with IBS for Study on the Mechanism of New Molecular Compounds
검색 닫기